Healthcare Services

Global cartilage degeneration market to reach $17.71B by 2030 at 5.9% CAGR

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Cartilage Degeneration Market From 2026 To 2030?

The cartilage degeneration market has experienced substantial growth in recent years. This market is set to expand from $13.4 billion in 2025 to $14.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.0%. Historically, this growth can be attributed to the increasing incidence of osteoarthritis, the expansion of orthopedic surgical procedures, a rising aging population, the availability of advanced surgical techniques, and the adoption of joint preservation therapies.

The cartilage degeneration market is anticipated to show significant growth in the coming years. It is forecast to grow to $17.72 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period can be attributed to increased investments in regenerative medicine research, an escalating demand for biologic cartilage repair solutions, the proliferation of stem cell-based therapies, a heightened focus on personalized orthopedic care, and the rising adoption of advanced cartilage restoration procedures. Notable trends for the forecast period include the increasing uptake of cell-based cartilage repair methods, the growing application of minimally invasive surgical techniques, an escalating demand for regenerative medicine solutions, the broadening use of advanced imaging and diagnostic tools, and an enhanced emphasis on long-term joint preservation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

What Key Drivers Are Fueling The Growth Of The Cartilage Degeneration Market?

The rising incidence of obesity is anticipated to boost the expansion of the cartilage degeneration market in the future. Obesity refers to a health condition marked by an excessive build-up of body fat, which can be detrimental to an individual’s well-being. This condition can trigger and speed up cartilage deterioration through elevated cartilage compressive forces and an increase in inflammatory cytokines. It leads to various pathological alterations within the entire knee joint structure, such as unusual joint loading, misalignment of the joint, and weakened muscles. As an example, data from November 2024 released by NHS Digital, a UK government health data agency, indicated that the rate of obesity among children aged 4 to 5 years climbed from 9.2% in 2022/23 to 9.6% in 2023/24. Consequently, the growing occurrence of obesity is fueling the expansion of the cartilage degeneration market.

How Is The Cartilage Degeneration Market Categorized Across Its Segment Groups?

The cartilage degeneration market covered in this report is segmented –

1) By Procedure: Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell-Based Cartilage Resurfacing, Autologous Chondrocyte Implantation, Other Procedures

2) By Application: Knee, Hip, Other Applications

3) By End User: Hospitals And Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes

Subsegments:

1) By Joint Replacements: Knee Replacement (Partial, Total), Hip Replacement (Partial, Total), Shoulder Replacement (Total, Reverse), Other Joints (Ankle, Elbow, Wrist)

2) By Chondroplasty: Radiofrequency Ablation Chondroplasty, Mechanical Chondroplasty, Thermal Chondroplasty, Arthroscopic Chondroplasty

3) By Osteochondral Transplants: Autografts (OATS), Allografts (Fresh Osteochondral Allografts), Synthetic Implants

4) By Microfracture: Traditional Microfracture, Augmented Microfracture (with scaffolds or matrix implants)

5) By Meniscus Transplants: Allograft Meniscus Transplantation (Cryopreserved, Fresh Frozen), Synthetic Meniscus Implants

6) By Cell-Based Cartilage Resurfacing: Autologous Cell-Based Therapy, Allogeneic Cell-Based Therapy, Stem Cell-Based Cartilage Repair

7) By Autologous Chondrocyte Implantation (ACI): First-Generation ACI, Second-Generation ACI, Third-Generation ACI (MACI)

8) By Other Procedures: Arthroscopic Debridement, Osteotomy, Cartilage Repair Using Synthetic Scaffolds, Injection-Based Therapies (Hyaluronic Acid, PRP, Stem Cell Injections)

What Trends Are Influencing The Cartilage Degeneration Market?

Leading companies within the cartilage degeneration market are emphasizing regenerative therapies to secure a competitive edge. Regenerative therapies leverage advanced biological techniques aimed at restoring or replacing compromised cartilage, thereby encouraging natural healing processes. For example, in 2023, Zimmer Biomet, a US-based medical device company, introduced its Tissue Regeneration System. This system employs a proprietary scaffold technology specifically engineered to boost cartilage repair. It incorporates biocompatible materials that support cell growth and integrate into surrounding tissues, notably enhancing healing outcomes. Furthermore, it provides customizable options designed for individual patient needs, thus improving its overall effectiveness. These developments indicate a broader movement towards personalized medicine in managing cartilage degeneration, addressing the rising incidence of osteoarthritis and sports-related injuries, while also facilitating quicker recovery periods and heightened patient satisfaction.

Which Firms Are Influencing Competition In The Cartilage Degeneration Market?

Major companies operating in the cartilage degeneration market are Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew plc, Osiris Therapeutics Inc., Arthrex Inc., Conmed Corporation, Orthocell Ltd., Bioventus LLC, Aesculap Inc., Vericel Corporation, Anika Therapeutics Inc., Geistlich Pharma AG, MatTek Corporation, Breg Inc., Isto Biologics Inc., OrthoTrophix LLC, CellGenix GmbH, CartiHeal Inc., Cayenne Medical Inc., Collagen Solutions plc, Regentis Biomaterials Ltd., Histogen Inc., BioTime Inc., CollPlant Holdings Ltd.

Get The Full Cartilage Degeneration Market Report:

https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

Which Region Represents The Largest Share Of The Cartilage Degeneration Market?

North America was the largest region in the cartilage degeneration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cartilage Degeneration Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

Browse Through More Reports Similar to the Global Cartilage Degeneration Market 2026, By The Business Research Company

Major Orthopedic Joint Replacement Implants Market 2026

https://www.thebusinessresearchcompany.com/report/major-orthopedic-joint-replacement-implants-market

Orthopedic Regenerative Surgical Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthopedic-regenerative-surgical-products-global-market-report

Orthopedic Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795